NCT05277272 INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
| NCT ID | NCT05277272 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital Medical Center, Cincinnati |
| Condition | Hemophagocytic Lymphohistiocytoses |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-12-31 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2021-12-31 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this observational study is to collect data on the natural history of disease of patients with Hemophagocytic Lymphohistiocytosis (HLH) including diagnosis, treatments, responses, and outcomes.
Eligibility Criteria
Inclusion Criteria: * Patients with clinically suspected or confirmed HLH, including those meeting the HLH-2004 diagnostic criteria (primary or secondary forms, including malignancy) and other forms of HLH (macrophage activation syndrome \[MAS\], cytokine release syndrome \[CRS\], etc.) * Signed and dated informed consent and assent (adolescents) Exclusion Criteria: * None
Contact & Investigator
Michael Jordan, MD
STUDY CHAIR
Children's Hospital Medical Center, Cincinnati
Frequently Asked Questions
Who can join the NCT05277272 clinical trial?
This trial is open to participants of all sexes, studying Hemophagocytic Lymphohistiocytoses. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05277272 currently recruiting?
Yes, NCT05277272 is actively recruiting participants. Contact the research team at Michael.Jordan@cchmc.org for enrollment information.
Where is the NCT05277272 trial being conducted?
This trial is being conducted at Cincinnati, United States.
Who is sponsoring the NCT05277272 clinical trial?
NCT05277272 is sponsored by Children's Hospital Medical Center, Cincinnati. The principal investigator is Michael Jordan, MD at Children's Hospital Medical Center, Cincinnati. The trial plans to enroll 200 participants.